Neurology Department, St George's University Hospital, United KingdomStroke and CNS inflammatory disease
Consultant Neurologist in the Neurology Department at St George’s University Hospitals NHS Foundation Trust, London, UK
UK Chief Investigator for the SWIFT‑Direct international thrombectomy trial, the first such study initiated from the UK, based at St George’s Hyper Acute Stroke Unit
Primary supervisor for a four-year PhD studentship exploring diabetes, retinal vasculopathy, and post-stroke cognitive decline, jointly administered between St George’s and University of Manchester
Department of Neurology, Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, ChinaEarly diagnosis and treatment of dementia; Cerebrovascular diseases; Clinical application of stem cell and gene therapy in the treatment of nervous system diseases
Director of Department of Neurology, Drum Tower Hospital, Nanjing University Medical School, China
Expert receiving Special Government Allowance of the State Council
Outstanding Chinese neurologist
Outstanding Leading Medical Talent in Jiangsu Province
Director of Provincial Cerebrovascular Disease Treatment Center, Jiangsu, China
Director of Provincial Key Disciplines and Key Clinical Specialties, Jiangsu, China
The current vice chairman of the Neurology Branch of the Chinese Medical Association
Vice-chairman of the Prevention and Control Professional Committee of the Chinese Preventive Medicine Association
Vice President of Neurology Branch of Chinese Medical Doctor Association
Chairman of the Stroke Branch of Jiangsu Medical Association
Stroke is the second leading cause of death and the leading disability worldwide. One in four people over age 25 will have a stroke in their lifetime. Endovascular thrombectomy is the most effective reperfusion treatment in ischemic stroke due to large vessel occlusion. However, there are still unanswered questions in selecting eligible patients thrombectomy with significant inequality issues in accessing of stroke care. Although management of vascular risk factors remains extremely important in stroke prevention, the discoveries in stroke genetics would enable the identification of high-risk individuals before the emergence of vascular risk factors and potential new treatment targets. There are over 101 million stroke survivals globally. Person-centered, collaborative rehabilitation still awaits more studies, especially on post-stroke cognitive rehab.
This stroke special issue will focus on acute stroke reperfusion, stroke genetics, post stroke rehabilitation, especially cognitive rehabilitation and inequality in stroke care.
Subclinical atrial fibrillation in embolic stroke of undetermined source: Management and stroke recurrence
Stroke care in sub-Saharan Africa: Evaluating the present landscape and proposing strategies for improving outcomes
Inflammation in ischemic stroke patients with type 2 diabetes – Part I: Atherosclerosis formation, acute ischemia, post-stroke infection, and long-term sequelae
Inflammation in ischemic stroke patients with type 2 diabetes – Part II: Potential therapeutic targets
Proteomic analysis of exosomes derived from detrimental and protective microglia
Trimethylamine N-oxide: A new target for the prevention and treatment of ischemic stroke
Rescue stenting in refractory mechanical thrombectomy: A review
Thirty years of the South London Stroke Register